[PDF] Top 20 A re-randomisation design for clinical trials

... of re-randomisation in the context of the SWIM (Sickle With Ibuprofen & Mor- phine) trial ...of randomisation, and so the follow-up period for most patients would be under five ...the ... See full document

... propose re- weighted versions of the usual score estimating equation and the score test in the Cox model to be used for the analysis of TSRD clinical ... See full document

... Population Clinical Trials Task Force that aim to contribute towards successful therapy development and clinical ...randomised clinical trials are still considered the gold standard, it ... See full document

... to clinical scientists, several regulatory questions/concerns ...of clinical data obtained from adaptive clinical trials with different levels of modifications to trial procedures and/or ... See full document

... The reporting bias is potentially very large (up to 3 standard errors for stage 1 only and up to 2 standard errors for stage 2) and is largest when the prevalence of the subgroup is small and subsequently decreases. When ... See full document

... per design, there is a 80% chance to select population 1 correctly and reject the corresponding hypothesis. The selection probability of the full population increases as the prevalence increases as the effect in ... See full document

... during clinical trials involving simvastatin, atorvastatin became ...The design of every study which uses an “intention to treat” analysis includes an allowance for indi- viduals to crossover to the ... See full document

... effective trials. In this study we evaluated the potential impact of re-randomization on ...allowing trials to be completed more quickly. At the extreme, we estimated that re-randomization ... See full document

... TB clinical trials investigators has proposed consensus definitions for effi- cacy endpoints (culture conversion, death, unfavorable outcome, favorable outcome, cure, treatment failure, ... See full document

... The article selection and data extraction was conducted by one statistician (LF). A subjective decision was made about whether the trial should be included and whether the trial was adaptive. The decisions made should be ... See full document

... All clinical trials included in this review were obtained from peer-reviewed journals investigating the effective- ness of dry needling and/or injections of MTrPs asso- ciated with plantar heel ...either ... See full document

... study design and the conduct of the ...a clinical trial with multiple endpoints may be justified by the nature of the disease and the type of questions that a clinical trial aims to ... See full document

... the design and interpretation of clinical trials targeting ...Most clinical trials targeting NF-related tumors are 24 cycles (approximately 2 years), which is a sufficient amount of ... See full document

... a clinical trial compared with a non-health setting. Around half of trials included in the Cochrane review were health related (patient groups, population health surveys and surveys of healthcare ... See full document

... Abstract: Randomized controlled trials provide the best evidence, and is seen as the gold standard for allopathic research. Herbal therapies are not an integral part of conventional care although they are still ... See full document

... The CODA trial was designed to assess the efficacy and safety of once daily dosing (OD) versus three times daily dosing (TDS) of mesalazine over a 12-month period for patients in remission with ulcerative colitis. The ... See full document

... By design adaptations may not be as flexible as they are meant to be when there is a prospectively planned adap- tation embedded in the original statistical ...real clinical practices, which may give ... See full document

... placebo-controlled clinical drug ...A clinical trial was defined as a prospective study with human subjects that is intended to assess the efficacy, safety, or pharmacokinetics (absorption, distribution, ... See full document

... Reporting Trials; CRASH-2 trial: Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage Trial; CTU: clinical trials unit; DIC: disseminated intravascular coagulation; ... See full document

... optimal design framework, general (multivariate) models for continuous responses were discussed in detail in Fedorov and Hackl (1997); for binary responses, several bivariate models have been studied such as ... See full document